rs572530276

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_020631.6(PLEKHG5):​c.620C>T​(p.Ser207Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00017 in 1,540,266 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. S207S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00027 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00016 ( 0 hom. )

Consequence

PLEKHG5
NM_020631.6 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 1.13

Publications

1 publications found
Variant links:
Genes affected
PLEKHG5 (HGNC:29105): (pleckstrin homology and RhoGEF domain containing G5) This gene encodes a protein that activates the nuclear factor kappa B (NFKB1) signaling pathway. Mutations in this gene are associated with autosomal recessive distal spinal muscular atrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
PLEKHG5 Gene-Disease associations (from GenCC):
  • neuromuscular disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Charcot-Marie-Tooth disease recessive intermediate C
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • neuronopathy, distal hereditary motor, autosomal recessive 4
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.02110058).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000269 (41/152322) while in subpopulation AFR AF = 0.000601 (25/41568). AF 95% confidence interval is 0.000418. There are 0 homozygotes in GnomAd4. There are 17 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLEKHG5NM_020631.6 linkc.620C>T p.Ser207Leu missense_variant Exon 8 of 21 ENST00000377728.8 NP_065682.2 O94827-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLEKHG5ENST00000377728.8 linkc.620C>T p.Ser207Leu missense_variant Exon 8 of 21 2 NM_020631.6 ENSP00000366957.3 O94827-5

Frequencies

GnomAD3 genomes
AF:
0.000269
AC:
41
AN:
152204
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000603
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000266
AC:
37
AN:
139108
AF XY:
0.000241
show subpopulations
Gnomad AFR exome
AF:
0.000855
Gnomad AMR exome
AF:
0.000249
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000119
Gnomad OTH exome
AF:
0.000490
GnomAD4 exome
AF:
0.000159
AC:
221
AN:
1387944
Hom.:
0
Cov.:
35
AF XY:
0.000180
AC XY:
123
AN XY:
683336
show subpopulations
African (AFR)
AF:
0.000605
AC:
19
AN:
31404
American (AMR)
AF:
0.000283
AC:
10
AN:
35294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24916
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35574
South Asian (SAS)
AF:
0.000812
AC:
64
AN:
78804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
44962
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5412
European-Non Finnish (NFE)
AF:
0.0000940
AC:
101
AN:
1074084
Other (OTH)
AF:
0.000470
AC:
27
AN:
57494
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000269
AC:
41
AN:
152322
Hom.:
0
Cov.:
34
AF XY:
0.000228
AC XY:
17
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.000601
AC:
25
AN:
41568
American (AMR)
AF:
0.000588
AC:
9
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68016
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000112
Hom.:
0
Bravo
AF:
0.000314
ExAC
AF:
0.0000590
AC:
4
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neuronopathy, distal hereditary motor, autosomal recessive 4 Uncertain:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Inborn genetic diseases Uncertain:1
Aug 01, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.620C>T (p.S207L) alteration is located in exon 8 (coding exon 7) of the PLEKHG5 gene. This alteration results from a C to T substitution at nucleotide position 620, causing the serine (S) at amino acid position 207 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Neuronopathy, distal hereditary motor, autosomal recessive 4;C3809309:Charcot-Marie-Tooth disease recessive intermediate C Uncertain:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 207 of the PLEKHG5 protein (p.Ser207Leu). This variant is present in population databases (rs572530276, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with PLEKHG5-related conditions. ClinVar contains an entry for this variant (Variation ID: 297968). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
May 23, 2022
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
15
DANN
Uncertain
1.0
DEOGEN2
Benign
0.20
.;.;.;.;.;.;.;.;T;T
Eigen
Benign
-0.46
Eigen_PC
Benign
-0.31
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.88
D;.;D;D;D;D;.;D;D;D
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.021
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.6
.;.;.;.;.;.;.;.;L;.
PhyloP100
1.1
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-1.9
N;N;N;N;N;N;N;N;N;N
REVEL
Benign
0.27
Sift
Benign
0.12
T;T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.17
T;T;T;T;T;T;T;T;T;T
Polyphen
0.0090, 0.0030, 0.0050
.;.;.;.;B;B;.;.;B;B
Vest4
0.083
MVP
0.57
MPC
0.23
ClinPred
0.012
T
GERP RS
3.8
Varity_R
0.075
gMVP
0.54
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs572530276; hg19: chr1-6533486; COSMIC: COSV105907272; COSMIC: COSV105907272; API